LUMAKRAS (Page 5 of 5)
PRINCIPAL DISPLAY PANEL — 120 mg Tablet Bottle Carton Label — NDC 55513-488-02
NDC 55513-488-02
LUMAKRAS™
(sotorasib) TABLETS
120 mg
Each tablet contains 120 mg sotorasib.
Store at 20°C to 25°C (68°F to 77°F). Excursionspermitted from 15°C to 30°C (59°F to 86°F).
Recommended Dosage: See Prescribing Information.
AMGEN®
PRINCIPAL DISPLAY PANEL — 120 mg Tablet Bottle Carton Label — NDC 55513-488-24
NDC 55513-488-24
LUMAKRAS™
(sotorasib) TABLETS
120 mg
Each tablet contains 120 mg sotorasib.
Store at 20°C to 25°C (68°F to 77°F).
Excursions permitted from 15°C to 30°C
(59°F to 86°F).
Recommended Dosage: See PrescribingInformation.
AMGEN®
PRINCIPAL DISPLAY PANEL — 320 mg Tablet Bottle Carton Label
NDC 55513-504-50
LUMAKRAS®
(sotorasib) TABLETS
320 mg | New strength
Each tablet contains 320 mg sotorasib.
Store at 20°C to 25°C (68°F to 77°F).
Excursions permitted from 15°C to 30°C
(59°F to 86°F).
Recommended Dosage: See PrescribingInformation.
AMGEN®
LUMAKRAS sotorasib tablet, coated | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
|
LUMAKRAS sotorasib tablet, coated | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
Labeler — Amgen Inc (039976196) |
Registrant — Amgen, Inc (039976196) |
Revised: 10/2023 Amgen Inc
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.